Skin hydration: Maypharm and Beauty Factory collab on hybrid mesotherapy filler

Maypharm Co., Ltd. has globally launched Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler designed to redefine skin hydration and revitalization. An innovator in medical and dermo-cosmetic products, Maypharm said the Hyalmass Aqua-Exosome is a hybrid filler combining the power of hyaluronic acid, exosomes, and PDRN to maximize skin hydration, elasticity, and regeneration. Unlike traditional hydration fillers that focus solely on moisture, Hyalmass Aqua-Exosome elevates skin health standards by leveraging the regenerative potential of exosomes and PDRN.

Key features of Hyalmass Aqua-Exosome

1. Advanced formulation: Hyalmass Aqua-Exosome contains a unique blend of hyaluronic acid, exosomes derived from human stem cell conditioned media and plant sources, and PDRN (polydeoxyribonucleotide). This innovative combination maximizes skin regeneration and elasticity, resulting in visibly smoother and more radiant skin.
2. Prefilled syringes: Hyalmass Aqua-Exosome comes conveniently packaged in prefilled syringes, ensuring optimal hygiene and safety for both patients and practitioners.
3. Long-lasting efficacy: Utilizing high-purity, high-molecular-weight raw materials, Hyalmass Aqua-Exosome delivers long-lasting benefits to the skin, enhancing its viscoelasticity and overall vitality.
4. Stimulates fibroblasts: The primary ingredient in Hyalmass Aqua-Exosome stimulates fibroblasts to promote collagen and elastin production, leading to improved skin elasticity, anti-aging effects, and enhanced skin regeneration.

"At Maypharm, we are committed to pushing the boundaries of aesthetic technology to deliver transformative results for our customers," says KWON JONGWOOK, CEO of Maypharm Co., Ltd. "With Hyalmass Aqua-Exosome, we aim to provide a comprehensive solution that not only hydrates the skin but also promotes long-term elasticity and regeneration."

While conventional hydration fillers deliver quick moisture, their benefits are often limited to hydration alone, offering minimal regenerative effects, according to Maypharm. In contrast, Hyalmass Aqua-Exosome not only provides immediate hydration with hyaluronic acid but also promotes long-term skin elasticity and regeneration through the inclusion of exosomes and PDRN. This innovative formulation leads to a significant overall improvement in skin condition, positioning Hyalmass Aqua-Exosome as a revolutionary advancement in aesthetics.

With the launch of Hyalmass Aqua-Exosome, Maypharm Co., Ltd. continues its commitment to innovation, excellence, and customer satisfaction in the field of cosmetic medicine and dermo-cosmetic products.

Partnership with Korea-based Beauty Factory

The production of Hyalmass Aqua-Exosome is supported by Beauty Factory, a leading Korean medical aesthetics manufacturer renowned for its commitment to innovation and quality. While Maypharm is responsible for the global distribution and commercialization of Hyalmass Aqua-Exosome, Beauty Factory's advanced manufacturing capabilities ensure that this product meets the highest industry standards.

Beauty Factory operates state-of-the-art facilities that comply with international Good Manufacturing Practice (GMP) guidelines. With their proprietary HALO manufacturing technology, developed through partnerships with prestigious academic institutions like KINS Lab at Seoul National University and the Biomaterial Synthesis Lab at Sookmyung University, Beauty Factory maintains its leadership in medical aesthetics. Their collaborations with renowned global R&D partners in Poland and Germany further enhance the scientific and technological advancements that support the creation of Hyalmass Aqua-Exosome. Furthermore, the 7-step quality control (QC) system that is in place at Beauty Factory guarantees that all products undergo meticulous testing to ensure consistent and reliable performance across all applications.